We are live on ! Find out more
APYX icon

Apyx Medical

32 hedge funds and large institutions have $22.1M invested in Apyx Medical in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more capital invested

Capital invested by funds: $13M → $22.1M (+$9.01M)

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

0% more funds holding

Funds holding: 3232 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

Holders
32
Holders Change
Holders Change %
0%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
11
Reduced
9
Closed
5
Calls
Puts
Net Calls
Net Calls Change

APYX Hedge Fund Activity: Q2 2015 in Review

32 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2015, worth a combined $22.1M — up 69% from $13M a quarter earlier.

Fund positioning in APYX was balanced in Q2 2015: 5 funds opened new positions, 5 closed out, 11 added to existing stakes and 9 trimmed.

The largest buyer was Great Point Partners, adding an estimated $6.05M. The largest seller was Northpointe Capital, exiting entirely with an estimated $359K sold.

  • 32 institutional investors held Apyx Medical (APYX) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $22.1M of Apyx Medical stock for Q2 2015, up 69% quarter-over-quarter.
  • 5 funds opened new Apyx Medical positions in Q2 2015 and 5 closed out, a net change of 0 holders.
  • The largest Apyx Medical buyer in Q2 2015 was Great Point Partners, an estimated $6.05M added.
  • The largest Apyx Medical seller in Q2 2015 was Northpointe Capital, an estimated $359K sold.

Based on aggregated 13F filings for Q2 2015.